Page last updated: 2024-12-05

2-amino-delta(2)-thiazoline-4-carboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-amino-delta(2)-thiazoline-4-carboxylic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-amino-Delta(2)-thiazoline-4-carboxylic acid : A 1,3-thiazole that is 4,5-dihydro-1,3-thiazole which is substituted at positions 2 and 4 by an amino and a carboxy group, respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID16526
CHEBI ID64777
SCHEMBL ID272903
MeSH IDM0065139

Synonyms (51)

Synonym
STL300750
nsc25069
2150-55-2
nsc-25069
4-thiazolecarboxylic acid, 2-amino-4,5-dihydro-
einecs 218-433-0
nsc 25069
2-amino-2-thiazoline-4-carboxylic acid
2-amino-delta(2)-thiazoline-4-carboxylic acid
2-amino-4,5-dihydrothiazole-4-carboxylic acid
2-amino-4-carboxythiazoline
2-thiazoline-4-carboxylic acid, 2-amino-
2-amino-4-thiazoline-4-carboxylic acid
2-amino-4,5-dihydro-1,3-thiazole-4-carboxylic acid
AC-076
AKOS005145103
2-amino-4-thiazolinic acid
FT-0662084
FT-0662085
AKOS007930201
2-amino-4,5-dihydro-thiazole-4-carboxylic acid
48431vn59g ,
unii-48431vn59g
CHEBI:64777
l-2-aminothiazoline-4-carboxylic acid
dl-2-amino-2-thiazolin-4-carboxylic acid
rac 2-aminothiazoline-4-carboxylic acid
dl-2-aminothiazoline-4-carboxylic acid
2-iminothiazolidine-4-carboxylic acid
2-amino-4,5-dihydro-4-thiazolecarboxylic acid
2-aminothiazoline-4-carboxylic acid
dl-2-amino-2-thiazoline-4-carboxylic acid
FT-0634073
SCHEMBL272903
(sr)-2-amino-4,5-dihydro-1,3-thiazole-4-carboxylic acid
mfcd00010067
VHPXSBIFWDAFMB-UHFFFAOYSA-N
2-amino-4,5-dihydro-1,3-thiazole-4-carboxylic acid #
2-amino-4-carboxythiazole, 4,5-dihydro-
dl-2-amino-thiazoline-4-carboxylic acid
W-107546
dl-2-amino-.delta.2-thiazoline-4-carboxylic acid
DTXSID9024510
J-010496
2-azanyl-4,5-dihydro-1,3-thiazole-4-carboxylic acid
Q27133419
AS-20115
CS-0044002
4-thiazolecarboxylicacid,2-amino-4,5-dihydro-
2-amino-4,5-dihydrothiazole-4-carboxylicacid
4-thiazolecarboxylicacid,2-amino-4,5-dihydro-,(4s)-(9ci)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
1,3-thiazoles
sulfur-containing amino acid
amino acid zwitterionThe zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.85)18.7374
1990's1 (3.85)18.2507
2000's7 (26.92)29.6817
2010's14 (53.85)24.3611
2020's3 (11.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.06 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index5.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]